HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-05-22FDA Approved: NEVIRAPINE — Original Application (Micro Labs Limited)
FDA approved Nevirapine from Micro Labs Limited under an Original Application (ANDA) for the generic product. The approval confirms the gene…
-
FDA approval · 2012-05-22FDA Approved: NEVIRAPINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for nevirapine (generic) as an antiretroviral for HIV-1 infection.
-
FDA approval · 2012-05-22FDA Approved: NEVIRAPINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan Pharmaceuticals' original application for Nevirapine as a generic treatment for HIV-1 infection.
-
FDA approval · 2012-05-22FDA Approved: NEVIRAPINE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic nevirapine product from Aurobindo Pharma Limited under an Original Application for the treatment of HIV infection.
-
FDA approval · 2012-05-22FDA Approved: NEVIRAPINE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved the original application (ANDA) for NEVIRAPINE, a generic antiretroviral agent, manufactured by Amneal Pharmaceuticals LLC. Thi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-05-22FDA Approved: NEVIRAPINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's generic nevirapine under an Original Application (ANDA077521). It is indicated for HIV-1 infection a…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone [Phase 2]
A completed Phase II trial evaluating intermittent recombinant human interleukin-2 (rhIL-2) given intravenously or subcutaneously in HIV inf…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [Phase 2]
Phase 2 study evaluating how well different anti-HIV drugs can lower viral load after failure of nelfinavir therapy.
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [Phase 3]
Phase 3 trial evaluating whether adding efavirenz or nelfinavir to a lamivudine/zidovudine/indinavir regimen improves HIV treatment outcomes…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™ [Phase 1]
Phase 1 bioequivalence study assessing whether a fixed-dose combination tablet of maraviroc with lamivudine/zidovudine is bioequivalent to t…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [Phase 3]
Phase 3 trial comparing three initial HIV treatment regimens without protease inhibitors; the study is completed.
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 [NA]
Clinical trial update noting completion of a study assessing interleukin-2 in combination with HAART for HIV-infected patients previously en…
-
FDA approval · 2012-05-18FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Ziagen (abacavir sulfate) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study) [Phase 1]
Phase I study evaluating the safety and immunogenicity of the rgp120/HIV-1IIIB vaccine in healthy adults, with an extension for participants…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients [Phase 4]
This Phase 4 clinical trial in HIV-infected South African patients comparing stavudine versus tenofovir, each combined with lamivudine and e…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Study of Anti-HIV Therapy Intensification [NA]
A completed clinical trial update describes an intensification strategy for anti-HIV therapy. No results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Pilot Study of Raltegravir Lipodystrophy IISP [NA]
Update on a pilot clinical trial evaluating raltegravir for lipodystrophy in individuals with HIV infection.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients [NA]
This completed HIV prophylaxis trial reports discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-infect…
-
FDA approval · 2012-05-16FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie.
-
FDA approval · 2012-05-16FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) by AbbVie. This action approves changes to its labeling or ind…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine [Phase 2]
A Phase 2 clinical trial evaluated whether uridine supplementation can mitigate metabolic side effects associated with stavudine and zidovud…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects [Phase 2, Phase 3]
This document summarizes the results of a Phase 2/3 clinical trial evaluating maraviroc (UK-427,857) in combination with optimized backgroun…
-
CLINICAL_TRIALS research · 2012-05-15Clinical Trial Update: Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) [Phase 3]
This update reports on the Phase 3 evaluation of four simplified antiretroviral regimens in treatment-naive HIV-1–infected patients in Afric…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: Study of Valproic Acid to Treat HIV Infected Adults [Phase 1]
A Phase 1 study evaluating valproic acid for treatment of HIV infection has been terminated.
-
CLINICAL_TRIALS withdrawal · 2012-05-10Clinical Trial Update: HLA-B35 Alleles and AIDS
A clinical trial investigating HLA-B35 alleles and AIDS has been withdrawn.